| Literature DB >> 20731359 |
Anthony B Comeau1, David A Critton, Rebecca Page, Christopher T Seto.
Abstract
Protein tyrosine phosphatases such as PTP1B and YopH are potential targets for the development of therapeutic agents against a variety of pathological conditions including diabetes, obesity, and infection by the bacterium Yersinia pestis. A focused library of bidentate α-ketoacid-based inhibitors has been screened against several tyrosine phosphatases. Compound 2a has IC(50) values of 43 and 220 nM against YopH and PTP1B, respectively, and shows a 30-fold selectivity for PTP1B over the closely related phosphatase TCPTP.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20731359 DOI: 10.1021/jm100528p
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446